Craft

Affinivax

Total Funding

$348.5 M

Affinivax Summary

Company Summary

Overview
Affinivax is a vaccine development company intended to treat various infectious diseases. The company's vaccines are based on Multiple Antigen Presenting System (MAPS) and provide protection against infectious diseases afflicting children and adults in both the developing and developed worlds.
Type
Private
Status
Active
Founded
2014
HQ
Cambridge, MA, US | view all locations
Website
http://affinivax.com/
Cybersecurity rating
Sectors

Key People

  • Steven Brugger

    Steven Brugger, President and CEO, Director

  • Bob More, Chairman of the Board

    • Steven Altschuler, Director

      • Stuart Chaffee

        Stuart Chaffee, Chief Business Officer

        LocationsView all

        1 location detected

        • Cambridge, MA HQ

          United States

          301 Binney St #302

        Footer menu